Smith & Nephew plc (SN) Trading Down 0%
Smith & Nephew plc (LON:SN)’s share price fell 0% during trading on Friday . The stock traded as low as GBX 1,333 ($17.53) and last traded at GBX 1,319 ($17.35). 1,552,080 shares were traded during mid-day trading, a decline of 52% from the average session volume of 3,220,000 shares. The stock had previously closed at GBX 1,319 ($17.35).
Several research firms have recently commented on SN. Berenberg Bank reissued a “hold” rating and issued a GBX 1,340 ($17.62) target price on shares of Smith & Nephew in a report on Friday, November 3rd. J P Morgan Chase & Co lowered their target price on shares of Smith & Nephew from GBX 1,382 ($18.18) to GBX 1,369 ($18.01) and set a “neutral” rating on the stock in a report on Monday, November 13th. Jefferies Group LLC reissued a “buy” rating and issued a GBX 1,515 ($19.93) target price on shares of Smith & Nephew in a report on Monday, November 6th. Deutsche Bank AG boosted their target price on shares of Smith & Nephew from GBX 1,200 ($15.78) to GBX 1,315 ($17.30) and gave the stock a “hold” rating in a report on Monday, October 23rd. Finally, Citigroup Inc. reissued a “sell” rating and issued a GBX 1,160 ($15.26) target price on shares of Smith & Nephew in a report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of GBX 1,315.82 ($17.31).
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with Analyst Ratings Network's FREE daily email newsletter.